Roche Goes Big On KRAS-Mutated Cancers In Hookipa Pact

 
• By Alaric DeArment
  
Roche signed a deal with Hookipa worth $25m up front and up to $930m in milestones • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business